🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Schroth and Scapular Muscle Activation in Hyperkyphosis

RecruitingNAAges 7 Years - 18 YearsAllIstanbul University - Cerrahpasa
NCT06907914 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to investigate the effects of Schroth exercises on scapular muscle activation in children with thoracic hyperkyphosis. A total of 56 participants will be randomly assigned to either the Schroth exercise group or the control group receiving postural education. The intervention group will complete an 8-week supervised Schroth program focusing on three-dimensional correction, rotational breathing, and postural awareness. Primary outcome is scapular muscle activation measured by surface EMG. Secondary outcomes include muscle strength, scapular endurance, kyphotic appearance, posture, and pain. The results will guide clinical management and preventive strategies for children with postural thoracic hyperkyphosis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Thoracic kyphosis angle (Cobb) between ≥40° and \<70° on lateral radiographs * Aged 7-18 years * Risser stage 0-5, indicating ongoing skeletal development Exclusion Criteria: * Congenital or rigid spinal deformities/anomalies * Major musculoskeletal surgery or trauma, especially involving the spine * Physiotherapeutic intervention for the spine in the last 6 months * Current brace use * BMI ≥ 30 * Regular upper extremity sports involvement (e.g., swimming, volleyball) at least twice a week for one year * More than 60 minutes of moderate-to-high intensity physical activity per week * Visual impairments or light sensitivity * Positive vestibular (Unterberger) test * Hearing impairments * Cognitive difficulties affecting comprehension * Systemic diseases (diabetes, hypothyroidism, infection, malignancy) * Neurological disorders * Active rheumatic diseases
💊

What it tests

  • Schroth
📍

Where

1 site
Istanbul University-Cerrahpasa
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy